DITTO is a menstrual health company on a mission to break the taboo and close the research gap that has left women chronically underserved. Founded by neuroscientist and nutrition scientist Alice van der Schoot, DITTO launched its first product in 2025, combining clinical research and nutrient delivery technology to build trusted solutions for the menstrual cycle. DITTO also translates emerging research for a community of over 300,000, helping women understand their experiences, stay up to date, and feel equipped to advocate for themselves in a world that left them feeling unheard. DITTO is fast becoming the scientific authority in menstrual health, building the research infrastructure and science-led products this category has never had.
DITTO
- Health
- London, United Kingdom
- £4.5m
- dittodaily.com
- Update Information
More venture news
- 29 Jul 2026

MiraeMirae lands £4m in funding from Oxford Science Enterprises for conversational AI platform that tracks autoimmune disease between clinic visits
EquityHealth - 28 Jul 2026

DITTODITTO lands a £4.5m seed round led by FoodLabs to develop evidence-based menstrual health supplements
SeedHealth - 24 Jul 2026

TidalSenseTidalSense secures £14m in funding from VCs to roll out AI-driven breath test for lung disease
EquityHealth
